← back to search

Robert Mróz

Medical University of Białystok · PL
Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Lung Cancer Treatments and Mutations, Asthma and respiratory diseases, and Respiratory Support and Mechanisms.
h-index
21
citations
5,150
works
144
NIH funding
primary concept
Medicine
email

Recent publications

Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study
ESMO Open 2025cited by 5position: middledoi
AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD
ERJ Open Research 2024cited by 29position: middledoi
LBA51 Circulating tumor DNA (ctDNA) dynamics and treatment responses in chemotherapy-ineligible patients (pts) with unresectable stage III NSCLC from the phase II DUART trial
Annals of Oncology 2024cited by 3position: middledoi
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
JAMA 2022cited by 439position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rafał Dziadziuszko · Université Grenoble Alpes2 papers (2024–2025)Giuseppe Tonini · Campus Bio Medico University Hospital2 papers (2024–2025) · 2 papers (2024–2025)Carlo Genova · University of Parma2 papers (2024–2025)I. Toledano · Clinique Clémentville2 papers (2024–2025) · 2 papers (2024–2025)Andrea Riccardo Filippi · Fondazione IRCCS Istituto Nazionale dei Tumori2 papers (2024–2025) · 1 papers (2024–2024)Zhigang Zhu · Nanchang University1 papers (2024–2024) · 1 papers (2025–2025)David J. Lederer · Regeneron (United States)1 papers (2024–2024) · 1 papers (2025–2025)Diego Cortinovis · Università Campus Bio-Medico1 papers (2024–2024)Michel Djandji · Novartis (Switzerland)1 papers (2024–2024)Angelo Delmonte · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori1 papers (2025–2025) · 1 papers (2024–2024) · 1 papers (2024–2024)Christine Xu · University of Kansas1 papers (2024–2024) · 1 papers (2024–2024)Matthew P. Kosloski · Regeneron (United States)1 papers (2024–2024)